TY - JOUR
T1 - Quantification of reinforcing effectiveness
T2 - Comment on Meisch (2000)
AU - Carroll, M. E.
PY - 2000/1/1
Y1 - 2000/1/1
N2 - R. A. Meisch (2000) introduces an innovative method for quantifying the reinforcing effectiveness of drugs and other substances. Advantages are that it models the persistence of drug use in humans and its persistence ratios are the same whether responding or consumption is measured. Data indicate that the method is sensitive to factors that affect drug self-administration. The measure's core feature is 'the systematic variation of both reinforcer magnitude and schedule size' (Meisch, 2000, p. 347); however, the method may not be widely used with such extensive parametric analysis. Variation of only reinforcer magnitude (or dose/concentration) seems to produce similar results, and this abbreviated analysis is similar to the behavioral economic analysis of demand. When responding is plotted as a function of unit price (responses/milligram), the peak of the curve (where maximum responding occurs) is a measure of persistence. Further work will determine how these and other measures of reinforcing effectiveness agree.
AB - R. A. Meisch (2000) introduces an innovative method for quantifying the reinforcing effectiveness of drugs and other substances. Advantages are that it models the persistence of drug use in humans and its persistence ratios are the same whether responding or consumption is measured. Data indicate that the method is sensitive to factors that affect drug self-administration. The measure's core feature is 'the systematic variation of both reinforcer magnitude and schedule size' (Meisch, 2000, p. 347); however, the method may not be widely used with such extensive parametric analysis. Variation of only reinforcer magnitude (or dose/concentration) seems to produce similar results, and this abbreviated analysis is similar to the behavioral economic analysis of demand. When responding is plotted as a function of unit price (responses/milligram), the peak of the curve (where maximum responding occurs) is a measure of persistence. Further work will determine how these and other measures of reinforcing effectiveness agree.
UR - http://www.scopus.com/inward/record.url?scp=0033753017&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033753017&partnerID=8YFLogxK
U2 - 10.1037/1064-1297.8.3.352
DO - 10.1037/1064-1297.8.3.352
M3 - Review article
C2 - 10975623
AN - SCOPUS:0033753017
SN - 1064-1297
VL - 8
SP - 352
EP - 354
JO - Experimental and Clinical Psychopharmacology
JF - Experimental and Clinical Psychopharmacology
IS - 3
ER -